News2021 News Archive
December 20, 2021
With over 35 years in the reproductive medicine industry, Bernadette brings a wealth of experience to the partnership, said Jens Sønksen when welcoming her to ReproUnion's Executive Board in the autumn 2021.
November 5, 2021
The first week of November marks the European Fertility Week – and this year, for the first time ever, it is shedding light on male infertility issues and men’s health. More than 25 million citizens in the European Union are facing fertility issues today with male factor infertility occurring in around 40% of all infertile couples.
October 13, 2021
The world’s largest male offspring cohort to examine the fetal origin of adult reproductive function (FEPOS) was established as part of Katia Keglberg Hærvig’s PhD project, funded by ReproUnion.
August 9, 2021
On the 4th of August Nature published the findings from a global collaboration of scientists, who have identified nearly 300 gene variations that influence reproductive lifespan in women. This can lead to potential new targets for fertility treatments as well as ways to improve the prediction of early menopause.
August 5, 2021
In collaboration with scientists from 20 Universities around the world, ReproUnion colleagues at Rigshospitalet have uncovered how a gen-mutation is a reason for missing sperm cells. This is for the first time described in relation to infertility in a newly published article in the prestigious New England Journal of Medicine
June 29, 2021
In June, the message about the ReproUnion Biobank and Infertility Cohort (RUBIC) spread across Danish, Swedish and scientific media – exactly one year after RUBIC enrolled the first infertile couples!
June 29, 2021
In her PhD Nina Mørup Nygaard researched how both common and rare genetic variants play different, but significant roles for male reproduction. She further investigated how small non-coding RNAs can serve as biomarkers for testicular cancer and her results have been covered by various publications.
June 9, 2021
It is with great sadness that we received the news that Professor Bernard Jégou from Rennes, France, has passed away on the 11th of May 2021. Bernard Jegou was one of the world’s leading reproductive researchers and a person with whom scientific collaboration quickly developed into a friendship.
June 9, 2021
With their RESPOND project, Professors Eva Hoffmann and Anja Pinborg have received DKK 10 million from the Novo Nordisk Foundation and its Tandem Programme, which seeks to stimulate the transition of basic research to clinical practice and vice versa. Human oocyte aging is characterized by a decline in the number of oocytes and their genetic […]
April 28, 2021
On the 8th of April 2021, Professor Eva Hoffmann was among the first presenters at the virtual ’Best of ASRM & ESHRE 2021’ conference with her lecture on Molecular mechanisms behind women’s biological clock. The lecture was in the cutting-edge track, illustrating innovations and new findings in reproductive medicine and biology. Two days later Professor […]
March 26, 2021
In the opinion piece in Politiken, the authors Søren Ziebe, Lone Schmidt and Sophie Hæstorp Andersen bring up a sensitive, yet necessary topic, namely how reproductive challenges also impact our welfare model.
February 23, 2021
In February 2021 Henriette Svarre Nielsen stepped into ReproUnion’s Executive Board. Since 2018 she has been part of ReproUnion’s Challenge 2 and worked alongside colleagues in Greater Copenhagen to launch the ReproUnion Biobank & Infertility Cohort (RUBIC).
February 1, 2021
EU/Interreg, Region Hovedstaden, Region Skåne and Ferring are supporting ReproUnion with EUR 2.3 million to carry out additional reproductive research, which will assess the impact of the COVID-19 virus on fertility, pregnancy, and fetus.
January 18, 2021
Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. Here we feature Selma Kløve Landersø and Pernille Udesen, who were among the first to virtually defend their ReproUnion supported-PhDs during the COVID-19 pandemic.